Abl Bio Inc.

Mogam Biotechnology Institute

Green Cross Labcell

Hyejin Chung

Bora Lee

Yangsoon Lee

Yeunju Kim

Yu Kyeong Hwang

Donghoon Yeom

Kyeongsu Park

Kyungjin Park

Jiseon Yoo

Eunjung Kim

Youngkwang Kim

Jinwon Jung

Mikyung Chang

Jaehyoung Jeon

Junhyun Jeong

Okjae Lim

Bokyung Min

Jung Hyun Her

Hana Choi

Sangmi Kang

Eun-Kyoung Lee

Provided are an antibody or antigen-binding fragment thereof that specifically binds to a B-cell maturation antigen (BCMA), a method of preparing the same, and use thereof. Accordingly, these can be utilized in effectively preventing or treating cancers.

Anti-BCMA antibody and use thereof

The present invention relates to a method for producing natural killer cells (hereinafter, referred to as 'NK cells'), NK cells produced thereby, and a composition for treating cancers and infectious diseases containing the same. The present invention provides a method for producing NK cells, which maintain high cytotoxicity and cell viability to exhibit high therapeutic effects against cancers and infectious diseases and can be cultured ex vivo at high efficiency and high concentration. In addition, a culture method which maintains cell concentration at a constant level is used for the production of NK cells, and thus the overgrowth of the cells can be prevented so that the cells can be maintained at an optimal state. Particularly, even when the cells are thawed after freezing, the function of the cells is not impaired, and the NK cells can maintain high cell viability and cytotoxicity. Thus, the NK cells can be easily stored and supplied in a liquid or frozen state without needing an additional treatment process.

Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the same

Growing community of inventors

Gyeonggi-do, South Korea

Hyejin Chung